Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.06−0.39 (-11.16%)
Close on Nov 18, 2026Market cap $484.50KP/E –Yield –
Clearmind Medicine gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Clearmind Medicine
Clearmind Medicine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?